Investments Ltd Burford Cap... Net Worth

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Investments Cap JAGX stock SEC Form 4 insiders trading

Investments has made over 1 trades of the Jaguar Health Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Investments sold 325,615 units of JAGX stock worth $595,875 on 25 September 2018.

The largest trade Investments's ever made was selling 325,615 units of Jaguar Health Inc stock on 25 September 2018 worth over $595,875. On average, Investments trades about 325,615 units every 0 days since 2018.

You can see the complete history of Investments Cap stock trades at the bottom of the page.

What's Investments Cap's mailing address?

Investments's mailing address filed with the SEC is Glategny Esplanade, GY1, Guernsey.

Insiders trading at Jaguar Health Inc

Over the last 10 years, insiders at Jaguar Health Inc have traded over $596,652 worth of Jaguar Health Inc stock and bought 670,772 units worth $1,311,594 . The most active insiders traders include Capital Partners, L.P.Sagar..., James J Bochnowski a Investments Ltd Burford Cap.... On average, Jaguar Health Inc executives and independent directors trade stock every 66 days with the average trade being worth of $27,901. The most recent stock trade was executed by Pravin R Chaturvedi on 17 May 2024, trading 871 units of JAGX stock currently worth $984.

What does Jaguar Health Inc do?

jaguar health, inc. is a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. our wholly-owned subsidiary, napo pharmaceuticals, inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. our mytesi® (crofelemer) product is approved by the u.s. fda for the symptomatic relief of noninfectious diarrhea in adults with hiv/aids on antiretroviral therapy. canalevia™ is our lead animal prescription drug candidate, intended for treatment of various forms of diarrhea in dogs. equilevia™ is jaguar’s non-prescription product for total gut health in equine athletes. to read our full social media policy, please visit https://jaguar.health/social-media-policy/

Complete history of Investments Cap stock trades at Jaguar Health Inc

Jaguar Health Inc executives and stock owners

Jaguar Health Inc executives and other stock owners filed with the SEC include:

• Lisa Conte,
  President, Chief Executive Officer, Director
• Steven King,
  Executive Vice President - Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary
• Lisa A. Conte,
  Founder, CEO, Pres & Director
• Jonathan Wolin,
  Chief of Staff, General Counsel and Chief Compliance Officer
• Jonathan S. Wolin CPA, J.D., M.B.A.,
  Chief of Staff, Chief Compliance Officer & Gen. Counsel
• Dr. Steven R. King,
  Chief Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec.
• James Bochnowski,
  Independent Chairman of the Board
• Jonathan Siegel,
  Independent Director
• Jiahao Qiu,
  Independent Director
• John Micek,
  Independent Director
• Gregory Divis,
  Independent Director
• Melissa Yeager,
  Senior Vice President - Regulatory Affairs & Quality Assurance
• Carol Lizak,
  Senior Vice President - Finance, Chief Accounting Officer
• Melissa A. Yeager J.D.,
  Sr. VP of Regulatory Affairs & Quality Assurance
• Ian H. Wendt M.B.A.,
  Chief Commercial Officer
• David Sesin,
  Chief Manufacturing Officer
• Dr. Karen Brunke Ph.D.,
  Exec. VP of Corp. & Bus. Devel.
• Peter Hodge,
  Sr. Director of Investor Relations, Bus. Devel. & Special Events
• Dr. Pravin R. Chaturvedi Ph.D.,
  Chair of Scientific Advisory Board & Acting Chief Scientific Officer
• Carol R. Lizak,
  Chief Financial Officer
• Roger J. Waltzman,
  Chief Scientific Officer
• Folkert W. Kamphuis,
  Director
• Philippe Brianceau,
  Chief Veterinary Officer
• Murray David Mac Naughtan,
  
• Zhi Yang,
  Director
• Ari Azhir,
  Director
• Karen Steil Wright,
  CFO and Treasurer
• Jeffery C. Johnson,
  
• Jonathan M Glaser,
  
• Bryan Bryan Ezralow 1994 Tr...,
  
• Investments Ltd Burford Cap...,
  
• Capital Partners, L.P.Sagar...,
  
• John A Kallassy,
  CFO, COO, Treasurer
• Management, Ltd.Kunlun Phar...,
  
• Michael Hauser,
  Chf Veterinarian, Clinical Ops
• Anula Jayasuriya,
  Director
• Pravin R Chaturvedi,
  Chief Scientific Officer